Abu Dhabi Investment Authority (ADIA) and HarbourVest are exploring the possibility of acquiring a minority stake in Cohance Lifesciences, a Hyderabad-based pharmaceutical platform owned by Advent International. The investment is expected to be around $350-400 million, valuing Cohance Lifesciences at approximately $1.5 billion. ADIA already has a presence in India’s pharmaceutical sector, owning a stake in Intas Pharmaceuticals.
Saudi Arabia has announced its intention to consider establishing an office of its sovereign wealth fund in GIFT City, India, to facilitate investments. Saudi investment minister, Khalid A. Al Falih, stated that a strong delegation will be sent to GIFT City in the coming weeks to explore this opportunity. The minister also expressed interest in bidirectional investment facilitation between Saudi Arabia and India.
